Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
06/08/1999 | US5910573 Monomeric and dimeric antibody-fragment fusion proteins |
06/08/1999 | US5910481 Hybrid proteins with modified activity |
06/08/1999 | US5910451 Trophinin and trophinin-assisting proteins |
06/08/1999 | US5910435 Exposing protein with non-native disulfide bonds to non-protein compound with pka less than 8 and eo greater than -0.25 volts; for proper conformation of heterologous eukaryotic proteins from prokaryotic hosts |
06/08/1999 | US5910431 Polynucleotides encoding chemokine α-2 |
06/08/1999 | US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50) |
06/08/1999 | US5910428 Dna which codes for corticotropin-releasing factor binding protein; treating of eating disorders, alcholism; hypertensive agents |
06/08/1999 | US5910427 Protein derivatives formed by replacement, substitution, or chemical modification of amino acids 57 and/or 60 having increased activity; for immunosuppressives/allergy treatments |
06/08/1999 | US5910418 Immunoassay to identify prematurely terminated gene products; diagnosis of familial adenomatous polyposis |
06/08/1999 | US5910416 Adrenomedullin |
06/08/1999 | US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme |
06/08/1999 | US5910405 HCV diagnostic agents |
06/08/1999 | CA2242308A1 Novel compounds |
06/08/1999 | CA1340587C Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
06/04/1999 | CA2253011A1 Dna encoding neospora dihydrofolate reductase-thymidylate synthase |
06/03/1999 | WO1999027129A1 Virulence-associated nucleic acid sequences and uses thereof |
06/03/1999 | WO1999027128A1 ribH |
06/03/1999 | WO1999027127A1 NOVEL ribB |
06/03/1999 | WO1999027126A1 ribG |
06/03/1999 | WO1999027125A1 ribA |
06/03/1999 | WO1999027121A1 Development of viruses resistant to inactivation by the human complement system |
06/03/1999 | WO1999027106A1 NOVEL guaA |
06/03/1999 | WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
06/03/1999 | WO1999027100A1 Fibroblast growth factor-19 |
06/03/1999 | WO1999027098A2 A-33 related antigens and their pharmacological uses |
06/03/1999 | WO1999027096A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
06/03/1999 | WO1999027081A2 Alpha/beta hydrolase-fold enzymes |
06/03/1999 | WO1999027080A2 Human protein kinase and kinase inhibitors |
06/03/1999 | WO1999026975A2 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained |
06/03/1999 | WO1999026973A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | WO1999026972A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | WO1999026967A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | WO1999026961A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | WO1999026959A1 NOVEL recJ |
06/03/1999 | WO1999026650A1 ribB |
06/03/1999 | WO1999026646A1 ribA |
06/03/1999 | WO1999026463A2 Tnf ligand family gene |
06/03/1999 | WO1999019360A9 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies |
06/03/1999 | WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/03/1999 | WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/03/1999 | WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies |
06/03/1999 | WO1999012965A3 April- a novel protein with growth effects |
06/03/1999 | WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
06/03/1999 | WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
06/03/1999 | WO1999009166A3 Prostate tumor polynucleotide and antigen compositions |
06/03/1999 | WO1999006552B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
06/03/1999 | WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
06/03/1999 | WO1999006550B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
06/03/1999 | WO1998058957A9 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
06/03/1999 | CA2311683A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | CA2310987A1 Tnf ligand family gene |
06/03/1999 | CA2310565A1 Human protein kinase and kinase inhibitors |
06/03/1999 | CA2310561A1 Virulence-associated nucleic acid sequences and uses thereof |
06/03/1999 | CA2310214A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | CA2309897A1 A novel egf motif protein obtained from a cdna library of fetal liver-spleen |
06/03/1999 | CA2309782A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | CA2309718A1 Secreted proteins and polynucleotides encoding them |
06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
06/03/1999 | CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
06/03/1999 | CA2253633A1 Complex specific antibodies, method of preparation and uses thereof |
06/02/1999 | EP0919617A1 Anti-human mp52 monoclonal antibody |
06/02/1999 | EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus |
06/02/1999 | EP0918873A1 Peptide with inhibitory activity towards plant pathogenic fungi |
06/02/1999 | EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
06/02/1999 | EP0918870A1 Chitinase materials and methods |
06/02/1999 | EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE |
06/02/1999 | EP0918863A1 Frozen food product containing heat stable antifreeze protein |
06/02/1999 | EP0918860A2 Tumor necrosis factor-related polypeptide |
06/02/1999 | EP0918859A1 Testis-specific insulin homolog polypeptides |
06/02/1999 | EP0918856A2 Two human nsp-like proteins |
06/02/1999 | EP0918855A1 Polycystic kidney disease gene |
06/02/1999 | EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN |
06/02/1999 | EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
06/02/1999 | EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
06/02/1999 | EP0918752A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
06/02/1999 | EP0693084A4 Chimeric cytokine receptors in lymphocytes |
06/02/1999 | EP0680513B1 Lysosomal targeting of immunogens |
06/02/1999 | EP0631631B1 A process for producing heme proteins |
06/02/1999 | CN1218509A Improved barster gene |
06/02/1999 | CN1218411A Method of killing target cells in harvested cell populations |
06/02/1999 | CN1218112A Protein production process |
06/02/1999 | CA2223075A1 Drug binding protein |
06/01/1999 | US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol |
06/01/1999 | US5908827 Protein from urine named component B |
06/01/1999 | US5908790 Methods for removing heavy metals from aqueous solutions and for analysis |
06/01/1999 | US5908781 Hybridoma cell line producing antibodies; from immunization composition of desfuryol antibiotic conjugated to carrier through thio group |
06/01/1999 | US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
06/01/1999 | US5908756 Protein inhibitor of neuronal nitric oxide synthase |
06/01/1999 | US5908627 Antigen associated with Type I diabetes mellitus |
06/01/1999 | US5908626 Genetic engineering |
06/01/1999 | CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus |
06/01/1999 | CA2097698C Human dopamine d4 receptor and its uses |
06/01/1999 | CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides |
06/01/1999 | CA1340568C Creatine kinase mb determination method |
05/27/1999 | WO1999025864A2 HIGH MOLECULAR WEIGHT η-POLY(GLUTAMIC ACID) |
05/27/1999 | WO1999025849A1 Single-chain bifunctional glycoprotein hormones |
05/27/1999 | WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods |
05/27/1999 | WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
05/27/1999 | WO1999025832A1 Toso |